Multimodal Neurodegenerative Disease Subtyping Explained by ChatGPT
Alzheimer's disease (AD) is the most prevalent neurodegenerative disease; yet its currently available treatments are limited to stopping disease progression. Moreover, effectiveness of these treatments is not guaranteed due to the heterogenetiy of the disease. Therefore, it is essential to be able to identify the disease subtypes at a very early stage. Current data driven approaches are able to classify the subtypes at later stages of AD or related disorders, but struggle when predicting at the asymptomatic or prodromal stage. Moreover, most existing models either lack explainability behind the classification or only use a single modality for the assessment, limiting scope of its analysis. Thus, we propose a multimodal framework that uses early-stage indicators such as imaging, genetics and clinical assessments to classify AD patients into subtypes at early stages. Similarly, we build prompts and use large language models, such as ChatGPT, to interpret the findings of our model. In our framework, we propose a tri-modal co-attention mechanism (Tri-COAT) to explicitly learn the cross-modal feature associations. Our proposed model outperforms baseline models and provides insight into key cross-modal feature associations supported by known biological mechanisms.
Code (0)
등록된 구현이 없습니다.
Similar Papers 제목 키워드 기반
Disease Knowledge Transfer across Neurodegenerative Diseases
We introduce Disease Knowledge Transfer (DKT), a novel technique for transferring biomarker information between related neurodegenerative diseases. DKT infers robust multimodal biomarker trajectories in rare neurodegener…
Transfer LearningFeature-based Transformer with Incomplete Multimodal Brain Images for Diagnosis of Neurodegenerative Diseases
Benefiting from complementary information, multimodal brain imaging analysis has distinct advantages over single-modal methods for the diagnosis of neurodegenerative diseases such as Alzheimer’s disease. However, multi-m…
A Quantitative Analysis of Multimodal Biomarkers in Alzheimer's Disease
Despite increasing adoption of multimodal approaches in Alzheimer's Disease (AD) research -- aimed at integrating molecular, structural, clinical, and genetic biomarkers to enhance disease characterization -- the relatio…
Unifying Acoustic Features and Text with Multimodal LLMs for Neurodegenerative Screening
Voice-based screening offers a scalable and non-invasive way to assess neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD), but their staging remains challenging due to the difficulty…
Modelling the Neuroanatomical Progression of Alzheimer's Disease and Posterior Cortical Atrophy
In order to find effective treatments for Alzheimer's disease (AD), we need to identify subjects at risk of AD as early as possible. To this end, recently developed disease progression models can be used to perform early…
Transfer Learning